Jason Douglas Wilson, Chief Financial Officer at REATA PHARMACEUTICALS INC (RETA), sold 8,000 shares at $82.08 ($668K) on 2019-06-17, disclosed to the SEC on 2019-06-19.
Open-market sale of $668k RETA by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $82.08 | 600 | $49K | 7.4% |
| 2 | $82.08 | 600 | $49K | 7.4% |
| 3 | $83.20 | 1,357 | $113K | 16.9% |
| 4 | $83.20 | 1,357 | $113K | 16.9% |
| 5 | $84.02 | 1,548 | $130K | 19.5% |
| 6 | $84.02 | 1,548 |
| $130K |
| 19.5% |
| 7 | $84.76 | 495 | $42K | 6.3% |
| 8 | $84.76 | 495 | $42K | 6.3% |
| Total | $83.54 avg | 8,000 | $668K | 100% |
| Filing → |
| RETA | SELL | 2019-10-15 | $5.5M | — | Filing → |
| RETA | SELL | 2019-08-16 | $420K | — | Filing → |
| RETA | SELL | 2019-07-17 | $574K | — | Filing → |